A short oral presentation of the best E-POSTERS, moderated by Michaël Somers ( UZ Antwerpen)
A36 - It only takes 25 days to build a hepatitis C care network for people who inject drugs.
W. VERLINDEN (1), J. SCHOUTEN (1), C. MATHEÏ (2), T. WINDELINCKX (2) / [1] AZ Nikolaas, Sint-Niklaas, [2] Free Clinic vzw Antwerp
A31 - The prevalence and risk factors of hepatitis B viral infection in Middle Limburg Belgium: the importance of migration.
Ö. KOC (1), C. KREMER (1), R. BIELEN (1), D. BUSSCHOTS (1), N. HENS (1), F. NEVENS(2), G. ROBAEYS (3) / [1] U Hasselt, [2] KU Leuven, [3] Ziekenhuis Oost Limbug (ZOL)
B20 - RUMINATION SYNDROME AND SUPRA-GASTRIC BELCHING CAN BE DIAGNOSED BASED ON A 24 HOUR PH-IMPEDANCE MONITORING.
H. GEYSEN, E. CLEVERS, T. VANUYTSEL, J. TACK, A. PAUWELS / KU Leuven
I17 - Ultra-Proactive Therapeutic Drug Monitoring Incorporating Infliximab Point-Of-Care Testing With Ad Hoc Dose Adjustment Reduces C-reactive Protein Levels In Patients With IBD During Infliximab Maintenance Treatment.
P. BOSSUYT, E. HOEFKENS, I. GEERTS, F. VERBIEST, E. VERMEULEN, A. VAN OLMEN, L. POUILLON / Imelda Hospital, Bonheiden
I20 - Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single centre experience.
B. VERSTOCKT, C. CLAEYS, G. VAN ASSCHE, A. D'HOORE, A. WOLTHUIS, S. VERMEIRE, M. FERRANTE / UZ Leuven
I23 - The impact of storage time and freeze-thaw cycles on faecal calprotectin concentration in inflammatory bowel disease patients and controls.
C. CAENEPEEL (1), K. MACHIELS (1), S. VIEIRA-SILVA (2), M. FERRANTE (1), S. VERMEIRE (1) / [1] KU Leuven, [2] Rega Institute for Medical Research, Leuven
O14 - Independent Cohort Validation of the Negative Prognostic Impact of High Visceral Adipose Tissue Density in Advanced Colorectal Cancer.
C. VANDEPUTTE, A. DELEPORTE, T. GUIOT, L. AMEYE, M. PAESMANS, P. FLAMEN, A. HENDLISZ / ULB Bordet
O16 - Personalised selective internal radiation therapy improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.
H. LEVILLAIN (1), I. DURAN DERIJCKERE (1), L. AMEYE (1), T. GUIOT (1), A. BRAAT (2), B. VANDERLINDEN (1), N. REYNAERT (1), A. HENDLISZ (1), M. LAM (2), C. DEROOSE (3), H. AHMADZADEHFAR (4), P. FLAMEN (1) / [1] ULB Bordet, [2] University Medical Center Utrecht, Netherlands (the), [3] UZ Leuven, [4] University Hospital Bonn, Germany
